Form4insider filings, from the source

SEC Form 4 · accession 0001225208-18-009351

CORCEPT THERAPEUTICS INC · CORT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
May 11, 2018
Accepted (ET)
May 15, 2018 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 11, 2018M30,000$2.23A806,838D
Common StockF2,F1May 11, 2018S30,000$16.0104D776,838D
Common StockF3holding———2,613,634IBy Ltd Partnership
Common StockF4holding———955,055IBy Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right To Buy)F1$2.23May 11, 2018M30,000DJul 10, 2008Jun 10, 2018Common Stock30,0000D

Explanation of responses